Viewing Study NCT06171750


Ignite Creation Date: 2025-12-24 @ 4:58 PM
Ignite Modification Date: 2026-02-26 @ 3:17 AM
Study NCT ID: NCT06171750
Status: RECRUITING
Last Update Posted: 2025-07-18
First Post: 2023-11-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Sponsor: Ankyra Therapeutics, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module